Takeda Price Book Value Ratio from 2010 to 2024

TAK Stock  USD 13.36  0.01  0.07%   
Takeda Pharmaceutical Price Book Value Ratio yearly trend continues to be quite stable with very little volatility. The value of Price Book Value Ratio is projected to decrease to 0.59. From the period between 2010 and 2024, Takeda Pharmaceutical, Price Book Value Ratio regression line of its data series had standard deviation of  1.19 and standard deviation of  1.19. View All Fundamentals
 
Price Book Value Ratio  
First Reported
2010-12-31
Previous Quarter
0.62
Current Value
0.59
Quarterly Volatility
1.18557351
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Takeda Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Takeda main balance sheet or income statement drivers, such as Depreciation And Amortization of 867.8 B, Interest Expense of 204.9 B or Selling General Administrative of 760.9 B, as well as many exotic indicators such as Price To Sales Ratio of 0.92, Dividend Yield of 0.0775 or PTB Ratio of 0.59. Takeda financial statements analysis is a perfect complement when working with Takeda Pharmaceutical Valuation or Volatility modules.
  
This module can also supplement Takeda Pharmaceutical's financial leverage analysis and stock options assessment as well as various Takeda Pharmaceutical Technical models . Check out the analysis of Takeda Pharmaceutical Correlation against competitors.

Latest Takeda Pharmaceutical's Price Book Value Ratio Growth Pattern

Below is the plot of the Price Book Value Ratio of Takeda Pharmaceutical Co over the last few years. It is Takeda Pharmaceutical's Price Book Value Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Takeda Pharmaceutical's overall financial position and show how it may be relating to other accounts over time.
Price Book Value Ratio10 Years Trend
Slightly volatile
   Price Book Value Ratio   
       Timeline  

Takeda Price Book Value Ratio Regression Statistics

Arithmetic Mean1.49
Geometric Mean1.17
Coefficient Of Variation79.48
Mean Deviation0.84
Median1.42
Standard Deviation1.19
Sample Variance1.41
Range4.5418
R-Value(0.75)
Mean Square Error0.67
R-Squared0.56
Significance0
Slope(0.20)
Total Sum of Squares19.68

Takeda Price Book Value Ratio History

2024 0.59
2023 0.62
2021 0.48
2020 0.61
2019 0.54
2018 0.85
2017 1.97

About Takeda Pharmaceutical Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Takeda Pharmaceutical income statement, its balance sheet, and the statement of cash flows. Takeda Pharmaceutical investors use historical funamental indicators, such as Takeda Pharmaceutical's Price Book Value Ratio, to determine how well the company is positioned to perform in the future. Although Takeda Pharmaceutical investors may use each financial statement separately, they are all related. The changes in Takeda Pharmaceutical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Takeda Pharmaceutical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Takeda Pharmaceutical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Takeda Pharmaceutical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price Book Value Ratio 0.62  0.59 

Currently Active Assets on Macroaxis

When determining whether Takeda Pharmaceutical is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Takeda Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Takeda Pharmaceutical Co Stock. Highlighted below are key reports to facilitate an investment decision about Takeda Pharmaceutical Co Stock:
Check out the analysis of Takeda Pharmaceutical Correlation against competitors.
Note that the Takeda Pharmaceutical information on this page should be used as a complementary analysis to other Takeda Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Takeda Stock analysis

When running Takeda Pharmaceutical's price analysis, check to measure Takeda Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Takeda Pharmaceutical is operating at the current time. Most of Takeda Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Takeda Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Takeda Pharmaceutical's price. Additionally, you may evaluate how the addition of Takeda Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Is Takeda Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Takeda Pharmaceutical. If investors know Takeda will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Takeda Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.12)
Dividend Share
184
Earnings Share
0.36
Revenue Per Share
1.3 K
Quarterly Revenue Growth
0.013
The market value of Takeda Pharmaceutical is measured differently than its book value, which is the value of Takeda that is recorded on the company's balance sheet. Investors also form their own opinion of Takeda Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Takeda Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Takeda Pharmaceutical's market value can be influenced by many factors that don't directly affect Takeda Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Takeda Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Takeda Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Takeda Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.